This is the authors' abstract. We don't add key points for this paper.
Developmental and epileptic encephalopathy (DEE) encompasses severe epilepsies with early-onset seizures, typically within the first year of life. Genetic analysis is pivotal for early diagnosis and management. This study explores DEE’s clinical manifestations and genetic underpinnings in children. A group of 25 patients diagnosed with DEE underwent Whole Exome Sequencing (WES) facilitated by the University College London (UCL) following the provision of consent. The analysis involved a thorough examination of clinical data and genetic profiles to identify pathogenic variants. Pathogenicity of all the variants has been checked through InterVar, and ClinVar. After the WES, a total of 22 variants were found, from which seven were novel (c.215G>A, c.72del, c.423dup, c.1146_1171dup, c.1087T>C, c.298_307del, and c.2597del) and fifteen were previously reported pathogenic or likely pathogenic variants. Three mutations have been observed in duplicates (c.311G>A, c.1087T>C, c.739_745del). The study underscores DEE’s diverse phenotypes, providing insights into its broad clinical spectrum and genetic factors. It enhances diagnostic strategies, advances disease understanding, and may guide personalized treatments for affected children.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Javed et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: